Allspring Global Investments
AKRO

Allspring Global Investments’s Akero Therapeutics AKRO Stock Holding History

Allspring Global Investments’s Portfolio AKRO Stock Details AKRO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-482
Closed -$24.4K – 2226
2023
Q3 		$24.4K Sell
482
-900
-65% -$41.9K ﹤0.01% 2466
2023
Q2 		$64.5K Buy
1,382
+35
+3% +$1.6K ﹤0.01% 2215
2023
Q1 		$51.5K Sell
1,347
-185
-12% -$8.25K ﹤0.01% 2277
2022
Q4 		$84K Sell
1,532
-34
-2% -$1.46K ﹤0.01% 2137
2022
Q3 		$53K Buy
+1,566
New +$24K ﹤0.01% 2325

Other funds holding AKRO

State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Alkeon Capital Management
Alkeon Capital Management New York $59.5B AUM 51.63% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Allspring Global Investments's AKRO Position: Q4 2023 in Review

Allspring Global Investments sold out of Akero Therapeutics (AKRO) in Q4 2023, closing a stake of 482 shares — an estimated $24.4K sold.

Allspring Global Investments first reported a position in AKRO in Q3 2022 and held it in 5 quarters. The position peaked at $84K in Q4 2022. 157 funds tracked by Wall St. Rank hold AKRO as of Q4 2023.

  • Allspring Global Investments reported no remaining Akero Therapeutics position as of Q4 2023 after selling out during the quarter.
  • Allspring Global Investments sold 482 Akero Therapeutics shares in Q4 2023, an estimated $24.4K.
  • Allspring Global Investments first reported a position in Akero Therapeutics in Q3 2022 and held it in 5 quarters.
  • Allspring Global Investments's Akero Therapeutics position peaked at $84K in Q4 2022.
  • 157 funds tracked by Wall St. Rank held Akero Therapeutics as of Q4 2023.

Based on Allspring Global Investments's 13F filing for Q4 2023, filed 25 Jan 2024.